Intuitive Surgical, Inc. (NASDAQ:ISRG) Insider Mark Brosius Sells 2,115 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) insider Mark Brosius sold 2,115 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the transaction, the insider now directly owns 295 shares in the company, valued at approximately $145,113.45. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Intuitive Surgical Stock Down 0.3 %

Intuitive Surgical stock opened at $482.09 on Thursday. The stock has a market cap of $171.00 billion, a PE ratio of 87.02, a P/E/G ratio of 5.41 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $496.18. The business’s 50-day moving average price is $466.24 and its two-hundred day moving average price is $423.80.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm’s revenue was up 14.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.18 EPS. As a group, analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on ISRG shares. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $475.00 to $495.00 and gave the stock an “overweight” rating in a report on Friday, July 19th. Evercore ISI dropped their target price on shares of Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a report on Friday, July 19th. Truist Financial boosted their price target on Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a research report on Tuesday, July 16th. Barclays raised their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. Finally, Stifel Nicolaus boosted their target price on Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a report on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $446.45.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. One Wealth Management Investment & Advisory Services LLC raised its position in Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after purchasing an additional 23 shares during the last quarter. Indiana Trust & Investment Management CO raised its holdings in Intuitive Surgical by 5.3% in the 2nd quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after buying an additional 25 shares during the last quarter. Hoxton Planning & Management LLC boosted its position in Intuitive Surgical by 4.9% during the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock worth $238,000 after buying an additional 25 shares during the period. First Affirmative Financial Network grew its holdings in Intuitive Surgical by 2.7% during the 2nd quarter. First Affirmative Financial Network now owns 996 shares of the medical equipment provider’s stock worth $443,000 after acquiring an additional 26 shares during the last quarter. Finally, Moors & Cabot Inc. increased its position in Intuitive Surgical by 2.3% in the 2nd quarter. Moors & Cabot Inc. now owns 1,159 shares of the medical equipment provider’s stock valued at $516,000 after acquiring an additional 26 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.